Clinical trial
Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic…
NCT00109356 · Novacea, Industry · Unknown status
Key facts
| NCT number | NCT00109356 |
|---|---|
| Title | Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia |
| Official title | A Phase 1/2, Open Label, Dose Escalation Study of AQ4N for Safety, Tolerability, Pharmacokinetics and Activity in Patients With Lymphoid Neoplasms |
| Lead sponsor | Novacea, Industry |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia |
| Intervention type | Drug |
| Interventions | AQ4N (Chemotherapy) |
| Enrollment | 55 |
| Start date | Mar 1, 2005 |
| Completion | Mar 1, 2007 |
| First posted | Apr 27, 2005 |
| Last update posted | May 7, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: